{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T01:53:48Z","timestamp":1772589228984,"version":"3.50.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100006710","name":"Wayne State University","doi-asserted-by":"crossref","award":["UROP"],"award-info":[{"award-number":["UROP"]}],"id":[{"id":"10.13039\/100006710","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100006710","name":"Wayne State University","doi-asserted-by":"crossref","award":["UROP"],"award-info":[{"award-number":["UROP"]}],"id":[{"id":"10.13039\/100006710","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Tactogen Inc"},{"name":"Tactogen Inc."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"DOI":"10.1007\/s00213-026-07010-1","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T01:01:48Z","timestamp":1772586108000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A repeated low-dose regimen of MDMA has transient next-day effects on locomotor activity, anxiety-like behavior, and brain serotonin levels, with no effect on anhedonia-like behavior, in both female and male rats"],"prefix":"10.1007","author":[{"given":"Ava M.","family":"Mac","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srinivasu","family":"Kallakuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alixandria T.","family":"Mascarin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grant W.","family":"LeVasseur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saniya","family":"Haq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew M.","family":"Moua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdul H.","family":"Vasiq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makayla E.","family":"Lewis-Gates","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily J.","family":"Thompson-Huber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew J.","family":"Baggott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shane A.","family":"Perrine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"issue":"2","key":"7010_CR2","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1080\/02791072.2019.1580805","volume":"51","author":"W Barone","year":"2019","unstructured":"Barone W, Jerome B, Michiko MW, Perl P (2019) Perceived benefits of MDMA-assisted psychotherapy beyond symptom reduction: qualitative follow-up study of a clinical trial for individuals with treatment-resistant PTSD. J Psychoactive Drugs 51(2):199\u2013208. https:\/\/doi.org\/10.1080\/02791072.2019.1580805","journal-title":"J Psychoactive Drugs"},{"key":"7010_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24109086","author":"A Baslam","year":"2023","unstructured":"Baslam A, Aitbaba A, Hanchi AL, Tazart Z, Aboufatima R, Soraa N, Ait-El-Mokhtar M, Boussaa S, Baslam M, Chait A (2023) Modulation of gut microbiome in ecstasy\/MDMA-induced behavioral and biochemical impairment in rats and potential of post-treatment with Anacyclus pyrethrum L. aqueous extract to mitigate adverse effects. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24109086","journal-title":"Int J Mol Sci"},{"issue":"2","key":"7010_CR4","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.pbb.2008.02.018","volume":"90","author":"MH Baumann","year":"2008","unstructured":"Baumann MH, Clark RD, Rothman RB (2008) Locomotor stimulation produced by 3,4-methylenedioxymethamphetamine (MDMA) is correlated with dialysate levels of serotonin and dopamine in rat brain. Pharmacol Biochem Behav 90(2):208\u2013217. https:\/\/doi.org\/10.1016\/j.pbb.2008.02.018","journal-title":"Pharmacol Biochem Behav"},{"issue":"4","key":"7010_CR5","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s00213-006-0322-6","volume":"189","author":"MH Baumann","year":"2007","unstructured":"Baumann MH, Wang X, Rothman RB (2007) 3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings. Psychopharmacology 189(4):407\u2013424. https:\/\/doi.org\/10.1007\/s00213-006-0322-6","journal-title":"Psychopharmacology"},{"issue":"11","key":"7010_CR6","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1124\/dmd.109.028506","volume":"37","author":"MH Baumann","year":"2009","unstructured":"Baumann MH, Zolkowska D, Kim I, Scheidweiler KB, Rothman RB, Huestis MA (2009) Effects of dose and route of administration on pharmacokinetics of (\u00b1)-3,4-methylenedioxymethamphetamine in the rat. Drug Metab Dispos 37(11):2163\u20132170. https:\/\/doi.org\/10.1124\/dmd.109.028506","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"7010_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-024-02742-0","volume":"14","author":"JP Berrio","year":"2024","unstructured":"Berrio JP, Hestehave S, Kalliokoski O (2024) Reliability of sucrose preference testing following short or no food and water deprivation\u2014a systematic review and meta-analysis of rat models of chronic unpredictable stress. Transl Psychiatry 14(1):39. https:\/\/doi.org\/10.1038\/s41398-024-02742-0","journal-title":"Transl Psychiatry"},{"issue":"4","key":"7010_CR8","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1111\/j.1471-4159.2009.06515.x","volume":"112","author":"DK Biezonski","year":"2010","unstructured":"Biezonski DK, Meyer JS (2010) Effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin transporter and vesicular monoamine transporter 2 protein and gene expression in rats: implications for MDMA neurotoxicity. J Neurochem 112(4):951\u2013962. https:\/\/doi.org\/10.1111\/j.1471-4159.2009.06515.x","journal-title":"J Neurochem"},{"issue":"1","key":"7010_CR9","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0278-5846(88)90061-9","volume":"12","author":"M Carlsson","year":"1988","unstructured":"Carlsson M, Carlsson A (1988) A regional study of sex differences in rat brain serotonin. Prog Neuropsychopharmacol Biol Psychiatry 12(1):53\u201361. https:\/\/doi.org\/10.1016\/0278-5846(88)90061-9","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"7010_CR10","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1124\/dmd.113.053678","volume":"42","author":"M Concheiro","year":"2014","unstructured":"Concheiro M, Baumann MH, Scheidweiler KB, Rothman RB, Marrone GF, Huestis MA (2014) Nonlinear pharmacokinetics of (\u00b1)3,4-Methylenedioxymethamphetamine (MDMA) and its pharmacodynamic consequences in the rat. Drug Metab Dispos 42(1):119\u2013125. https:\/\/doi.org\/10.1124\/dmd.113.053678","journal-title":"Drug Metab Dispos"},{"issue":"6","key":"7010_CR11","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1038\/sj.npp.1300662","volume":"30","author":"G Conductier","year":"2005","unstructured":"Conductier G, Crosson C, Hen R, Bockaert J, Compan V (2005) 3,4-N-methlenedioxymethamphetamine-induced hypophagia is maintained in 5-HT1B receptor knockout mice, but suppressed by the 5-HT2C receptor antagonist RS102221. Neuropsychopharmacology 30(6):1056\u20131063. https:\/\/doi.org\/10.1038\/sj.npp.1300662","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"7010_CR12","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S0162-3109(97)00084-2","volume":"38","author":"TJ Connor","year":"1998","unstructured":"Connor TJ, McNamara MG, Finn D, Currid A, O\u2019Malley M, Redmond AM, Kelly JP, Leonard BE (1998) Acute 3,4-methylenedioxymethamphetamine (MDMA) administration produces a rapid and sustained suppression of immune function in the rat. Immunopharmacology 38(3):253\u2013260. https:\/\/doi.org\/10.1016\/S0162-3109(97)00084-2","journal-title":"Immunopharmacology"},{"key":"7010_CR13","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.pnpbp.2013.09.021","volume":"48","author":"BM Cox","year":"2014","unstructured":"Cox BM, Shah MM, Cichon T, Tancer ME, Galloway MP, Thomas DM, Perrine SA (2014) Behavioral and neurochemical effects of repeated MDMA administration during late adolescence in the rat. Prog Neuropsychopharmacol Biol Psychiatry 48:229\u2013235. https:\/\/doi.org\/10.1016\/j.pnpbp.2013.09.021","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"7010_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ntt.2022.107076","volume":"91","author":"CJ Davidson","year":"2022","unstructured":"Davidson CJ, Svenson DW, Hannigan JH, Perrine SA, Bowen SE (2022) A novel preclinical model of environment-like combined benzene, toluene, ethylbenzene, and xylenes (BTEX) exposure: behavioral and neurochemical findings. Neurotoxicol Teratol 91:107076. https:\/\/doi.org\/10.1016\/j.ntt.2022.107076","journal-title":"Neurotoxicol Teratol"},{"issue":"3","key":"7010_CR16","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/(sici)1099-1077(199705\/06)12:3<221::Aid-hup854>3.0.Co;2-c","volume":"12","author":"D Davison","year":"1997","unstructured":"Davison D, Parrott AC (1997) Ecstasy (MDMA) in recreational users: self-reported psychological and physiological effects. Hum Psychopharmacol Clin Exp 12(3):221\u2013226. https:\/\/doi.org\/10.1002\/(sici)1099-1077(199705\/06)12:3%3C;221::Aidhup854%3E;3.0.Co;2-c","journal-title":"Hum Psychopharmacol Clin Exp"},{"issue":"2","key":"7010_CR17","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.pnpbp.2008.11.012","volume":"33","author":"A Duchesne","year":"2009","unstructured":"Duchesne A, Dufresne MM, Sullivan RM (2009) Sex differences in corticolimbic dopamine and serotonin systems in the rat and the effect of postnatal handling. Prog Neuropsychopharmacol Biol Psychiatry 33(2):251\u2013261. https:\/\/doi.org\/10.1016\/j.pnpbp.2008.11.012","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"7010_CR18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1080\/09687637.2023.2284643","volume":"32","author":"JWB Elsey","year":"2025","unstructured":"Elsey JWB, Wuestman VAF, Fieten A (2025) User perceptions of long-term costs and benefits of MDMA use: findings from a large online sample. Drugs Educ Prev Policy 32(1):29\u201341. https:\/\/doi.org\/10.1080\/09687637.2023.2284643","journal-title":"Drugs Educ Prev Policy"},{"key":"7010_CR19","doi-asserted-by":"publisher","unstructured":"Feduccia AA, Jerome L, Yazar-Klosinski B, Emerson A, Mithoefer MC, Doblin R (2019) Breakthrough for trauma treatment: safety and efficacy of MDMA-Assisted psychotherapy compared to Paroxetine and Sertraline [Review]. Front Psychiatry 10. https:\/\/doi.org\/10.3389\/fpsyt.2019.00650","DOI":"10.3389\/fpsyt.2019.00650"},{"issue":"3","key":"7010_CR20","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1159\/000082356","volume":"80","author":"TM Felton","year":"2004","unstructured":"Felton TM, Auerbach SB (2004) Changes in [gamma]-aminobutyric acid tone and extracellular serotonin in the dorsal raphe nucleus over the rat estrous cycle. Neuroendocrinology 80(3):152\u2013157. https:\/\/doi.org\/10.1159\/000082356","journal-title":"Neuroendocrinology"},{"key":"7010_CR21","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1590\/S0100-879X2011007500046","volume":"44","author":"V Ferraz-de-Paula","year":"2011","unstructured":"Ferraz-de-Paula V, Stankevicius D, Ribeiro A, Pinheiro ML, Rodrigues-Costa EC, Florio JC, Lapachinske SF, Moreau RLM, Palermo-Neto J (2011) Differential behavioral outcomes of 3,4-methylenedioxymethamphetamine (MDMA-ecstasy) in anxiety-like responses in mice. Braz J Med Biol Res 44:428\u2013437. https:\/\/doi.org\/10.1590\/S0100-879X2011007500046","journal-title":"Braz J Med Biol Res"},{"key":"7010_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.109101","volume":"229","author":"AD Gaulden","year":"2021","unstructured":"Gaulden AD, Burson N, Sadik N, Ghosh I, Khan SJ, Brummelte S, Kallakuri S, Perrine SA (2021) Effects of fentanyl on acute locomotor activity, behavioral sensitization, and contextual reward in female and male rats. Drug Alcohol Depend 229:109101. https:\/\/doi.org\/10.1016\/j.drugalcdep.2021.109101","journal-title":"Drug Alcohol Depend"},{"issue":"12","key":"7010_CR23","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1007\/s00213-023-06453-0","volume":"240","author":"A Gheidi","year":"2023","unstructured":"Gheidi A, Davidson CJ, Simpson SC, Yahya MA, Sadik N, Mascarin AT, Perrine SA (2023) Norepinephrine depletion in the brain sex-dependently modulates aspects of spatial learning and memory in female and male rats. Psychopharmacology 240(12):2585\u20132595. https:\/\/doi.org\/10.1007\/s00213-023-06453-0","journal-title":"Psychopharmacology"},{"issue":"2","key":"7010_CR24","doi-asserted-by":"publisher","first-page":"309","DOI":"10.2741\/s518","volume":"10","author":"MS Gold","year":"2018","unstructured":"Gold MS, Blum K, Febo M, Baron D, Modestino EJ, Elman I, Badgaiyan RD (2018) Molecular role of dopamine in anhedonia linked to reward deficiency syndrome (RDS) and anti- reward systems. Front Bioscience-Scholar 10(2):309\u2013325. https:\/\/doi.org\/10.2741\/s518","journal-title":"Front Bioscience-Scholar"},{"issue":"3","key":"7010_CR25","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1124\/pr.55.3.3","volume":"55","author":"AR Green","year":"2003","unstructured":"Green AR, Mechan AO, Elliott JM, O\u2019Shea E, Colado MI (2003) The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy). Pharmacol Rev 55(3):463\u2013508. https:\/\/doi.org\/10.1124\/pr.55.3.3","journal-title":"Pharmacol Rev"},{"issue":"1","key":"7010_CR26","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0014-2999(02)01820-4","volume":"446","author":"CG Gurtman","year":"2002","unstructured":"Gurtman CG, Morley KC, Li KM, Hunt GE, McGregor IS (2002) Increased anxiety in rats after 3,4-methylenedioxymethamphetamine: association with serotonin depletion. Eur J Pharmacol 446(1):89\u201396. https:\/\/doi.org\/10.1016\/S0014-2999(02)01820-4","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"7010_CR27","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0166-4328(03)00220-1","volume":"149","author":"YJ Ho","year":"2004","unstructured":"Ho YJ, Pawlak CR, Guo L, Schwarting RKW (2004) Acute and long-term consequences of single MDMA administration in relation to individual anxiety levels in the rat. Behav Brain Res 149(2):135\u2013144. https:\/\/doi.org\/10.1016\/S0166-4328(03)00220-1","journal-title":"Behav Brain Res"},{"issue":"9","key":"7010_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0185129","volume":"12","author":"C Hu","year":"2017","unstructured":"Hu C, Luo Y, Wang H, Kuang S, Liang G, Yang Y, Mai S, Yang J (2017) Re-evaluation of the interrelationships among the behavioral tests in rats exposed to chronic unpredictable mild stress. PLoS ONE 12(9):e0185129. https:\/\/doi.org\/10.1371\/journal.pone.0185129","journal-title":"PLoS ONE"},{"issue":"4","key":"7010_CR29","doi-asserted-by":"publisher","first-page":"187","DOI":"10.14712\/fb2014060040187","volume":"60","author":"S Karimi","year":"2014","unstructured":"Karimi S, Jahanshahi M, Golalipour MJ (2014) The effect of MDMA-induced anxiety on neuronal apoptosis in adult male rats\u2019 hippocampus. Folia Biol (Praha) 60(4):187\u2013191. https:\/\/doi.org\/10.14712\/fb2014060040187","journal-title":"Folia Biol (Praha)"},{"issue":"1","key":"7010_CR30","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/j.1369-1600.2007.00083.x","volume":"13","author":"FH Kobeissy","year":"2008","unstructured":"Kobeissy FH, Jeung JA, Warren MW, Geier JE, Gold MS (2008) Changes in leptin, ghrelin, growth hormone and neuropeptide-Y after an acute model of MDMA and methamphetamine exposure in rats. Addict Biol 13(1):15\u201325. https:\/\/doi.org\/10.1111\/j.1369-1600.2007.00083.x","journal-title":"Addict Biol"},{"key":"7010_CR31","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.pbb.2016.08.004","volume":"152","author":"MF Lazenka","year":"2017","unstructured":"Lazenka MF, Suyama JA, Bauer CT, Banks ML, Negus SS (2017) Sex differences in abuse-related neurochemical and behavioral effects of 3,4-methylenedioxymethamphetamine (MDMA) in rats. Pharmacol Biochem Behav 152:52\u201360. https:\/\/doi.org\/10.1016\/j.pbb.2016.08.004","journal-title":"Pharmacol Biochem Behav"},{"issue":"3","key":"7010_CR32","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1176\/appi.focus.20220088","volume":"21","author":"BR Lewis","year":"2023","unstructured":"Lewis BR, Byrne K (2023) A review of MDMA-assisted therapy for posttraumatic stress disorder. Focus 21(3):247\u2013256. https:\/\/doi.org\/10.1176\/appi.focus.20220088","journal-title":"Focus"},{"issue":"3","key":"7010_CR33","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0091-3057(98)00191-9","volume":"62","author":"HQ Lin","year":"1999","unstructured":"Lin HQ, Burden PM, Christie MJ, Johnston GAR (1999) The anxiogenic-like and anxiolytic-like effects of MDMA on mice in the elevated plus-maze: a comparison with amphetamine. Pharmacol Biochem Behav 62(3):403\u2013408. https:\/\/doi.org\/10.1016\/S0091-3057(98)00191-9","journal-title":"Pharmacol Biochem Behav"},{"issue":"3","key":"7010_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.1222","volume":"9","author":"MJ Lisieski","year":"2019","unstructured":"Lisieski MJ, Karavidha K, Gheidi A, Garibyan RL, Conti AC, Morrow JD, Perrine SA (2019) Divergent effects of repeated cocaine and novel environment exposure on locus coeruleus c-fos expression and brain catecholamine concentrations in rats. Brain Behav 9(3):e01222. https:\/\/doi.org\/10.1002\/brb3.1222","journal-title":"Brain Behav"},{"issue":"3","key":"7010_CR35","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/0014-2999(88)90717-0","volume":"152","author":"BJ Logan","year":"1988","unstructured":"Logan BJ, Laverty R, Sanderson WD, Yee YB (1988) Differences between rats and mice in MDMA (methylenedioxymethylamphetamine) neurotoxicity. Eur J Pharmacol 152(3):227\u2013234. https:\/\/doi.org\/10.1016\/0014-2999(88)90717-0","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"7010_CR36","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.bbr.2007.12.008","volume":"189","author":"V Ludwig","year":"2008","unstructured":"Ludwig V, Mihov Y, Schwarting RKW (2008) Behavioral and neurochemical consequences of multiple MDMA administrations in the rat: role of individual differences in anxiety-related behavior. Behav Brain Res 189(1):52\u201364. https:\/\/doi.org\/10.1016\/j.bbr.2007.12.008","journal-title":"Behav Brain Res"},{"issue":"11","key":"7010_CR38","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1038\/s41593-021-00924-3","volume":"24","author":"T Markovic","year":"2021","unstructured":"Markovic T, Pedersen CE, Massaly N, Vachez YM, Ruyle B, Murphy CA, Abiraman K, Shin JH, Garcia JJ, Yoon HJ, Alvarez VA, Bruchas MR, Creed MC, Mor\u00f3n JA (2021) Pain induces adaptations in ventral tegmental area dopamine neurons to drive anhedonia-like behavior. Nat Neurosci 24(11):1601\u20131613. https:\/\/doi.org\/10.1038\/s41593-021-00924-3","journal-title":"Nat Neurosci"},{"issue":"1","key":"7010_CR39","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/S0022-3565(24)34877-3","volume":"290","author":"M Mas","year":"1999","unstructured":"Mas M, Farr\u00e9 M, de la Torre R, Roset PN, Segura J, Ortu\u00f1o J, Cam\u00ed J (1999) Cardiovascular and Neuroendocrine Effects and Pharmacokinetics of 3,4-Methylenedioxymethamphetamine in Humans. J Pharmacol Exp Ther 290(1):136\u2013145. https:\/\/doi.org\/10.1016\/S0022-3565(24)34877-3","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"7010_CR40","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0304-3940(01)01992-9","volume":"308","author":"A Mayerhofer","year":"2001","unstructured":"Mayerhofer A, Kovar KA, Schmidt WJ (2001) Changes in serotonin, dopamine and noradrenaline levels in striatum and nucleus accumbens after repeated administration of the abused drug MDMA in rats. Neurosci Lett 308(2):99\u2013102. https:\/\/doi.org\/10.1016\/S0304-3940(01)01992-9","journal-title":"Neurosci Lett"},{"issue":"8","key":"7010_CR41","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1038\/sj.npp.1300185","volume":"28","author":"IS McGregor","year":"2003","unstructured":"McGregor IS, Clemens KJ, Van der Plasse G, Li KM, Hunt GE, Chen F, Lawrence AJ (2003) Increased anxiety 3 months after brief exposure to MDMA (\u2018Ecstasy\u2019) in rats: association with altered 5-HT transporter and receptor density. Neuropsychopharmacology 28(8):1472\u20131484. https:\/\/doi.org\/10.1038\/sj.npp.1300185","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"7010_CR42","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/s41591-021-01336-3","volume":"27","author":"JM Mitchell","year":"2021","unstructured":"Mitchell JM, Bogenschutz M, Lilienstein A, Harrison C, Kleiman S, Parker-Guilbert K, Ot\u2019alora GM, Garas W, Paleos C, Gorman I, Nicholas C, Mithoefer M, Carlin S, Poulter B, Mithoefer A, Quevedo S, Wells G, Klaire SS, van der Kolk B, Doblin R (2021) MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Nat Med 27(6):1025\u20131033. https:\/\/doi.org\/10.1038\/s41591-021-01336-3","journal-title":"Nat Med"},{"issue":"10","key":"7010_CR43","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1038\/s41591-023-02565-4","volume":"29","author":"JM Mitchell","year":"2023","unstructured":"Mitchell JM, Ot\u2019alora GM, van der Kolk B, Shannon S, Bogenschutz M, Gelfand Y, Paleos C, Nicholas CR, Quevedo S, Balliett B, Hamilton S, Mithoefer M, Kleiman S, Parker-Guilbert K, Tzarfaty K, Harrison C, de Boer A, Doblin R, Yazar-Klosinski B, MAPP2 Study Collaborator Group (2023) MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial. Nat Med 29(10):2473\u20132480. https:\/\/doi.org\/10.1038\/s41591-023-02565-4","journal-title":"Nat Med"},{"issue":"1","key":"7010_CR44","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0014-2999(01)01512-6","volume":"433","author":"KC Morley","year":"2001","unstructured":"Morley KC, Gallate JE, Hunt GE, Mallet PE, McGregor IS (2001) Increased anxiety and impaired memory in rats 3 months after administration of 3,4-methylenedioxymethamphetamine (Ecstasy). Eur J Pharmacol 433(1):91\u201399. https:\/\/doi.org\/10.1016\/S0014-2999(01)01512-6","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"7010_CR45","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.neuropharm.2004.01.002","volume":"46","author":"KC Morley","year":"2004","unstructured":"Morley KC, Li KM, Hunt GE, Mallet PE, McGregor IS (2004) Cannabinoids prevent the acute hyperthermia and partially protect against the 5-HT depleting effects of MDMA (Ecstasy) in rats. Neuropharmacology 46(7):954\u2013965. https:\/\/doi.org\/10.1016\/j.neuropharm.2004.01.002","journal-title":"Neuropharmacology"},{"issue":"3","key":"7010_CR46","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1111\/j.1471-4159.1990.tb02358.x","volume":"54","author":"JF Nash","year":"1990","unstructured":"Nash JF, Meltzer HY, Gudelsky GA (1990) Effect of 3,4-Methylenedioxymethamphetamine on 3,4-Dihydroxyphenylalanine accumulation in the striatum and nucleus accumbens. J Neurochem 54(3):1062\u20131067. https:\/\/doi.org\/10.1111\/j.1471-4159.1990.tb02358.x","journal-title":"J Neurochem"},{"key":"7010_CR47","doi-asserted-by":"publisher","DOI":"10.17226\/12910","volume-title":"Guide for the care and use of laboratory animals","author":"National Research Council","year":"2011","unstructured":"National Research Council (2011) Guide for the care and use of laboratory animals, 8th ed. National Academies Press (US). https:\/\/doi.org\/10.17226\/12910","edition":"8th ed"},{"issue":"6","key":"7010_CR48","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/S0278-5846(02)00250-6","volume":"26","author":"JF Navarro","year":"2002","unstructured":"Navarro JF, Maldonado E (2002) Acute and subchronic effects of MDMA (ecstasy) on anxiety in male mice tested in the elevated plus-maze. Prog Neuropsychopharmacol Biol Psychiatry 26(6):1151\u20131154. https:\/\/doi.org\/10.1016\/S0278-5846(02)00250-6","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"2","key":"7010_CR49","first-page":"138","volume":"61","author":"MH Nowland","year":"2011","unstructured":"Nowland MH, Hugunin KM, Rogers KL (2011) Effects of short-term fasting in male Sprague-Dawley rats. Comp Med 61(2):138\u2013144. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3079815\/","journal-title":"Comp Med"},{"issue":"36","key":"7010_CR50","doi-asserted-by":"publisher","first-page":"9196","DOI":"10.1523\/JNEUROSCI.1124-06.2006","volume":"26","author":"P Olausson","year":"2006","unstructured":"Olausson P, Jentsch JD, Tronson N, Neve RL, Nestler EJ, Taylor JR (2006) DeltaFosB in the nucleus accumbens regulates food-reinforced instrumental behavior and motivation. J Neurosci 26(36):9196\u20139204. https:\/\/doi.org\/10.1523\/JNEUROSCI.1124-06.2006","journal-title":"J Neurosci"},{"issue":"6","key":"7010_CR51","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.neuro.2010.08.005","volume":"31","author":"SA Perrine","year":"2010","unstructured":"Perrine SA, Ghoddoussi F, Michaels MS, Hyde EM, Kuhn DM, Galloway MP (2010) MDMA administration decreases serotonin but not N-acetylaspartate in the rat brain. Neurotoxicology 31(6):654\u2013661. https:\/\/doi.org\/10.1016\/j.neuro.2010.08.005","journal-title":"Neurotoxicology"},{"issue":"5","key":"7010_CR52","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1038\/sj.npp.1301491","volume":"33","author":"BJ Piper","year":"2008","unstructured":"Piper BJ, Fraiman JB, Owens CB, Ali SF, Meyer JS (2008) Dissociation of the neurochemical and behavioral toxicology of MDMA (\u2018Ecstasy\u2019) by Citalopram. Neuropsychopharmacology 33(5):1192\u20131205. https:\/\/doi.org\/10.1038\/sj.npp.1301491","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"7010_CR53","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s00213-009-1750-x","volume":"208","author":"A Plaza-Zabala","year":"2010","unstructured":"Plaza-Zabala A, Vi\u00f1als X, Maldonado R, Robledo P (2010) Effects of repeated MDMA administration on the motivation for palatable food and extinction of operant responding in mice. Psychopharmacology 208(4):563\u2013573. https:\/\/doi.org\/10.1007\/s00213-009-1750-x","journal-title":"Psychopharmacology"},{"issue":"5","key":"7010_CR54","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1038\/s41380-019-0506-1","volume":"25","author":"N Qu","year":"2020","unstructured":"Qu N, He Y, Wang C, Xu P, Yang Y, Cai X, Liu H, Yu K, Pei Z, Hyseni I, Sun Z, Fukuda M, Li Y, Tian Q, Xu Y (2020) A POMC-originated circuit regulates stress-induced hypophagia, depression, and anhedonia. Mol Psychiatry 25(5):1006\u20131021. https:\/\/doi.org\/10.1038\/s41380-019-0506-1","journal-title":"Mol Psychiatry"},{"key":"7010_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.physbeh.2021.113515","volume":"239","author":"S Rehn","year":"2021","unstructured":"Rehn S, Boakes RA, Badolato CJ, Rooney KB (2021) Sex differences in recovery from cognitive and metabolic impairments induced by supplementary sucrose in rats. Physiol Behav 239:113515. https:\/\/doi.org\/10.1016\/j.physbeh.2021.113515","journal-title":"Physiol Behav"},{"issue":"3","key":"7010_CR56","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1177\/026988110401800312","volume":"18","author":"V Sanchez","year":"2004","unstructured":"Sanchez V, O\u2019shea E, Saadat KS, Elliott JM, Colado MI, Green AR (2004) Effect of repeated (\u2018binge\u2019) dosing of MDMA to rats housed at normal and high temperature on neurotoxicdamage to cerebral 5-Ht and dopamine neurones. J Psychopharmacol 18(3):412\u2013416. https:\/\/doi.org\/10.1177\/026988110401800312","journal-title":"J Psychopharmacol"},{"issue":"23","key":"7010_CR57","doi-asserted-by":"publisher","first-page":"4095","DOI":"10.1016\/0006-2952(87)90566-1","volume":"36","author":"CJ Schmidt","year":"1987","unstructured":"Schmidt CJ, Taylor VL (1987) Depression of rat brain tryptophan hydroxylase activity following the acute administration of Methylenedioxymethamphetamine. Biochem Pharmacol 36(23):4095\u20134102. https:\/\/doi.org\/10.1016\/0006-2952(87)90566-1","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"7010_CR58","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0006-8993(03)02563-0","volume":"974","author":"LC Schmued","year":"2003","unstructured":"Schmued LC (2003) Demonstration and localization of neuronal degeneration in the rat forebrain following a single exposure to MDMA. Brain Res 974(1):127\u2013133. https:\/\/doi.org\/10.1016\/S0006-8993(03)02563-0","journal-title":"Brain Res"},{"key":"7010_CR59","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1037\/e495922006-004","volume":"136","author":"LS Seiden","year":"1993","unstructured":"Seiden LS, Woolverton WL, Lorens SA, Williams J, Corwin RL, Hata N, Olimski M (1993) Behavioral consequences of partial monoamine depletion in the CNS after methamphetamine-like drugs: the conflict between pharmacology and toxicology. NIDA Res Monogr 136:34\u201346. https:\/\/doi.org\/10.1037\/e495922006-004","journal-title":"NIDA Res Monogr"},{"issue":"1","key":"7010_CR60","doi-asserted-by":"publisher","DOI":"10.1155\/2024\/9899034","volume":"2024","author":"V Semmlinger","year":"2024","unstructured":"Semmlinger V, Leithner C, Kl\u00f6ck LM, Ranftl L, Ehring T, Schreckenbach M (2024) Prevalence and predictors of nonresponse to psychological treatment for PTSD: a meta-analysis. Depress Anxiety 2024(1):9899034. https:\/\/doi.org\/10.1155\/2024\/9899034","journal-title":"Depress Anxiety"},{"issue":"2","key":"7010_CR61","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41386-024-01972-6","volume":"50","author":"I Straumann","year":"2025","unstructured":"Straumann I, Avedisian I, Klaiber A, Varghese N, Eckert A, Rudin D, Luethi D, Liechti ME (2025) Acute effects of R-MDMA, S-MDMA, and racemic MDMA in a randomized double-blind cross-over trial in healthy participants. Neuropsychopharmacology 50(2):362\u2013371. https:\/\/doi.org\/10.1038\/s41386-024-01972-6","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"7010_CR62","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/sj.npp.1300347","volume":"29","author":"MR Thompson","year":"2004","unstructured":"Thompson MR, Li KM, Clemens KJ, Gurtman CG, Hunt GE, Cornish JL, McGregor IS (2004) Chronic fluoxetine treatment partly attenuates the long-term anxiety and depressive symptoms induced by MDMA (\u2018Ecstasy\u2019) in rats. Neuropsychopharmacology 29(4):694\u2013704. https:\/\/doi.org\/10.1038\/sj.npp.1300347","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"7010_CR63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0295926","volume":"19","author":"BA van der Kolk","year":"2024","unstructured":"van der Kolk BA, Wang JB, Yehuda R, Bedrosian L, Coker AR, Harrison C, Mithoefer M, Yazar-Klosinki B, Emerson A, Doblin R (2024) Effects of MDMA-assisted therapy for PTSD on self-experience. PLoS One 19(1):e0295926. https:\/\/doi.org\/10.1371\/journal.pone.0295926","journal-title":"PLoS One"},{"issue":"7","key":"7010_CR64","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13210","volume":"22","author":"KA van Galen","year":"2021","unstructured":"van Galen KA, ter Horst KW, Serlie MJ (2021) Serotonin, food intake, and obesity. Obes Rev 22(7):e13210. https:\/\/doi.org\/10.1111\/obr.13210","journal-title":"Obes Rev"},{"issue":"4","key":"7010_CR65","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00213-005-0174-5","volume":"189","author":"CD Verrico","year":"2007","unstructured":"Verrico CD, Miller GM, Madras BK (2007) MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment. Psychopharmacology 189(4):489\u2013503. https:\/\/doi.org\/10.1007\/s00213-005-0174-5","journal-title":"Psychopharmacology"},{"issue":"4","key":"7010_CR66","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s00213-006-0531-z","volume":"189","author":"QD Walker","year":"2007","unstructured":"Walker QD, Williams CN, Jotwani RP, Waller ST, Francis R, Kuhn CM (2007) Sex differences in the neurochemical and functional effects of MDMA in Sprague\u2013Dawley rats. Psychopharmacology 189(4):435\u2013445. https:\/\/doi.org\/10.1007\/s00213-006-0531-z","journal-title":"Psychopharmacology"},{"key":"7010_CR67","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.brainres.2011.04.039","volume":"1398","author":"AE Wallinga","year":"2011","unstructured":"Wallinga AE, Grahlmann C, Granneman RA, Koolhaas JM, Buwalda B (2011) Gender differences in hyperthermia and regional 5-HT and 5-HIAA depletion in the brain following MDMA administration in rats. Brain Res 1398:13\u201320. https:\/\/doi.org\/10.1016\/j.brainres.2011.04.039","journal-title":"Brain Res"},{"issue":"1","key":"7010_CR68","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1176\/appi.ajp.20230681","volume":"182","author":"AS Wolfgang","year":"2025","unstructured":"Wolfgang AS, Fonzo GA, Gray JC, Krystal JH, Grzenda A, Widge AS, Kraguljac NV, McDonald WM, Rodriguez CI, Nemeroff CB (2025) MDMA and MDMA-assisted therapy. Am J Psychiatry 182(1):79\u2013103. https:\/\/doi.org\/10.1176\/appi.ajp.20230681","journal-title":"Am J Psychiatry"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-026-07010-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-026-07010-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-026-07010-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T01:01:49Z","timestamp":1772586109000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-026-07010-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":65,"alternative-id":["7010"],"URL":"https:\/\/doi.org\/10.1007\/s00213-026-07010-1","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]},"assertion":[{"value":"17 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental procedures were approved by the Wayne State University Institutional Animal Care and Use Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"M.J.B. is employed by, has assigned patents to, and holds equity in Tactogen Inc. He has served as an advisor to Noetic Fund 2 and to Journey Clinical. This research work was supported by a research contract from Tactogen Inc. to Wayne State University (S.A.P. and S.K.) and by funding by the Wayne State Undergraduate Research Opportunities Program (A.M.M. and M.M.M.). All other authors declare they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}